State Street Corp Sells 19,968 Shares of CME Group Inc. $CME

09 Dec 2025, 13:40 by Tristan Rich · The Markets Daily

State Street Corp lessened its position in CME Group Inc. (NASDAQ:CME – Free Report) by 0.1% in the second quarter, HoldingsChannel.com reports. The fund owned 16,419,196 shares of the financial services provider’s stock after selling 19,968 shares during the period. State Street Corp’s holdings in CME Group were worth $4,525,459,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors also recently modified their holdings of CME. Jessup Wealth Management Inc increased its position in CME Group by 0.5% during the second quarter. Jessup Wealth Management Inc now owns 7,969 shares of the financial services provider’s stock worth $2,197,000 after buying an additional 36 shares during the last quarter. First Horizon Advisors Inc. lifted its position in shares of CME Group by 0.7% in the second quarter. First Horizon Advisors Inc. now owns 5,269 shares of the financial services provider’s stock valued at $1,453,000 after buying an additional 36 shares during the last quarter. Great Lakes Advisors LLC boosted its stake in shares of CME Group by 2.3% during the 1st quarter. Great Lakes Advisors LLC now owns 1,661 shares of the financial services provider’s stock worth $441,000 after acquiring an additional 37 shares during the period. MBM Wealth Consultants LLC raised its stake in CME Group by 2.7% in the 2nd quarter. MBM Wealth Consultants LLC now owns 1,422 shares of the financial services provider’s stock valued at $392,000 after acquiring an additional 37 shares during the period. Finally, Beaumont Financial Advisors LLC lifted its holdings in CME Group by 2.0% during the 2nd quarter. Beaumont Financial Advisors LLC now owns 1,952 shares of the financial services provider’s stock valued at $538,000 after purchasing an additional 38 shares during the last quarter. 87.75% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

CME has been the topic of several research analyst reports. Argus dropped their price objective on shares of CME Group from $308.00 to $295.00 in a research report on Friday, October 31st. Weiss Ratings reaffirmed a “buy (b)” rating on shares of CME Group in a research report on Wednesday, October 8th. TD Cowen boosted their price target on CME Group from $288.00 to $290.00 and gave the stock a “hold” rating in a report on Thursday, October 23rd. UBS Group cut their target price on shares of CME Group from $285.00 to $280.00 and set a “neutral” rating on the stock in a research report on Thursday, October 23rd. Finally, Raymond James Financial lowered their price objective on CME Group from $309.00 to $307.00 and set an “outperform” rating for the company in a research note on Monday, October 13th. Eight equities research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and three have issued a Sell rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $289.18.

Check Out Our Latest Report on CME

CME Group Price Performance

CME Group stock opened at $270.42 on Tuesday. The stock’s 50 day moving average price is $271.53 and its two-hundred day moving average price is $272.62. The stock has a market capitalization of $97.51 billion, a price-to-earnings ratio of 26.20, a PEG ratio of 4.22 and a beta of 0.28. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.02 and a current ratio of 1.02. CME Group Inc. has a 52-week low of $224.62 and a 52-week high of $290.79.

CME Group (NASDAQ:CME – Get Free Report) last posted its quarterly earnings results on Wednesday, October 22nd. The financial services provider reported $2.68 EPS for the quarter, topping analysts’ consensus estimates of $2.63 by $0.05. The business had revenue of $1.54 billion during the quarter, compared to analysts’ expectations of $1.56 billion. CME Group had a net margin of 58.84% and a return on equity of 14.61%. The business’s quarterly revenue was down 3.0% on a year-over-year basis. During the same period last year, the company posted $2.68 earnings per share. On average, equities analysts predict that CME Group Inc. will post 10.49 earnings per share for the current year.

CME Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 30th. Shareholders of record on Friday, December 12th will be paid a $1.25 dividend. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.8%. The ex-dividend date of this dividend is Friday, December 12th. CME Group’s dividend payout ratio (DPR) is 48.45%.

Insider Buying and Selling at CME Group

In other news, insider Timothy Francis Mccourt sold 379 shares of the business’s stock in a transaction dated Tuesday, September 16th. The shares were sold at an average price of $259.83, for a total transaction of $98,475.57. Following the completion of the sale, the insider directly owned 9,508 shares of the company’s stock, valued at $2,470,463.64. The trade was a 3.83% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, Director William R. Shepard purchased 262 shares of the company’s stock in a transaction that occurred on Thursday, September 25th. The stock was acquired at an average cost of $265.19 per share, for a total transaction of $69,479.78. Following the transaction, the director owned 258,459 shares in the company, valued at $68,540,742.21. This represents a 0.10% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Insiders have sold 2,147 shares of company stock valued at $562,079 over the last three months. Corporate insiders own 0.30% of the company’s stock.

CME Group Profile

(Free Report)